FDA Official Pulls Back On Estimates Of Cost To Inspect Foreign Drug Makers Properly

FDA Center for Drug Evaluation and Research Director Janet Woodcock on Thursday during a House hearing "backed away" from a Tuesday comment that the agency would need an estimated $225 million to improve inspections of foreign medication manufacturing plants, the Wall Street Journal reports (Mundy, Wall Street Journal, 5/2).

http://www.medicalnewstoday.com/articles/106197.php